Global Immuno-Cell Therapy Market Research Report 2024(Status and Outlook)
Report Overview
Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
This report provides a deep insight into the global Immuno-Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-Cell Therapy market in any manner.
Global Immuno-Cell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Market Segmentation (by Type)
Passive Immune (NK, LAK etc)
Active Immune
Market Segmentation (by Application)
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
This report provides a deep insight into the global Immuno-Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-Cell Therapy market in any manner.
Global Immuno-Cell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Market Segmentation (by Type)
Passive Immune (NK, LAK etc)
Active Immune
Market Segmentation (by Application)
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Immuno-Cell Therapy Market
- Overview of the regional outlook of the Immuno-Cell Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Immuno-Cell Therapy
1.2 Key Market Segments
1.2.1 Immuno-Cell Therapy Segment by Type
1.2.2 Immuno-Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNO-CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immuno-Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immuno-Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNO-CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Immuno-Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global Immuno-Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immuno-Cell Therapy Sales Sites, Area Served, Product Type
3.6 Immuno-Cell Therapy Market Competitive Situation and Trends
3.6.1 Immuno-Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 IMMUNO-CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immuno-Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNO-CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 IMMUNO-CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global Immuno-Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Immuno-Cell Therapy Price by Type (2019-2024)
7 IMMUNO-CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-Cell Therapy Market Sales by Application (2019-2024)
7.3 Global Immuno-Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Immuno-Cell Therapy Sales Growth Rate by Application (2019-2024)
8 IMMUNO-CELL THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Immuno-Cell Therapy Sales by Region
8.1.1 Global Immuno-Cell Therapy Sales by Region
8.1.2 Global Immuno-Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 MEDINET Co
9.1.1 MEDINET Co Immuno-Cell Therapy Basic Information
9.1.2 MEDINET Co Immuno-Cell Therapy Product Overview
9.1.3 MEDINET Co Immuno-Cell Therapy Product Market Performance
9.1.4 MEDINET Co Business Overview
9.1.5 MEDINET Co Immuno-Cell Therapy SWOT Analysis
9.1.6 MEDINET Co Recent Developments
9.2 Erytech
9.2.1 Erytech Immuno-Cell Therapy Basic Information
9.2.2 Erytech Immuno-Cell Therapy Product Overview
9.2.3 Erytech Immuno-Cell Therapy Product Market Performance
9.2.4 Erytech Business Overview
9.2.5 Erytech Immuno-Cell Therapy SWOT Analysis
9.2.6 Erytech Recent Developments
9.3 Seta Clinic Group
9.3.1 Seta Clinic Group Immuno-Cell Therapy Basic Information
9.3.2 Seta Clinic Group Immuno-Cell Therapy Product Overview
9.3.3 Seta Clinic Group Immuno-Cell Therapy Product Market Performance
9.3.4 Seta Clinic Group Immuno-Cell Therapy SWOT Analysis
9.3.5 Seta Clinic Group Business Overview
9.3.6 Seta Clinic Group Recent Developments
9.4 Takeda
9.4.1 Takeda Immuno-Cell Therapy Basic Information
9.4.2 Takeda Immuno-Cell Therapy Product Overview
9.4.3 Takeda Immuno-Cell Therapy Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Recent Developments
9.5 SBI Holdings
9.5.1 SBI Holdings Immuno-Cell Therapy Basic Information
9.5.2 SBI Holdings Immuno-Cell Therapy Product Overview
9.5.3 SBI Holdings Immuno-Cell Therapy Product Market Performance
9.5.4 SBI Holdings Business Overview
9.5.5 SBI Holdings Recent Developments
9.6 Oxford BioTherapeutics
9.6.1 Oxford BioTherapeutics Immuno-Cell Therapy Basic Information
9.6.2 Oxford BioTherapeutics Immuno-Cell Therapy Product Overview
9.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Product Market Performance
9.6.4 Oxford BioTherapeutics Business Overview
9.6.5 Oxford BioTherapeutics Recent Developments
9.7 Fate Therapeutics
9.7.1 Fate Therapeutics Immuno-Cell Therapy Basic Information
9.7.2 Fate Therapeutics Immuno-Cell Therapy Product Overview
9.7.3 Fate Therapeutics Immuno-Cell Therapy Product Market Performance
9.7.4 Fate Therapeutics Business Overview
9.7.5 Fate Therapeutics Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Immuno-Cell Therapy Basic Information
9.8.2 Gilead Sciences Immuno-Cell Therapy Product Overview
9.8.3 Gilead Sciences Immuno-Cell Therapy Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 Novartis
9.9.1 Novartis Immuno-Cell Therapy Basic Information
9.9.2 Novartis Immuno-Cell Therapy Product Overview
9.9.3 Novartis Immuno-Cell Therapy Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Osiris
9.10.1 Osiris Immuno-Cell Therapy Basic Information
9.10.2 Osiris Immuno-Cell Therapy Product Overview
9.10.3 Osiris Immuno-Cell Therapy Product Market Performance
9.10.4 Osiris Business Overview
9.10.5 Osiris Recent Developments
9.11 Vericel Corporation
9.11.1 Vericel Corporation Immuno-Cell Therapy Basic Information
9.11.2 Vericel Corporation Immuno-Cell Therapy Product Overview
9.11.3 Vericel Corporation Immuno-Cell Therapy Product Market Performance
9.11.4 Vericel Corporation Business Overview
9.11.5 Vericel Corporation Recent Developments
9.12 Fujifilm Cellular Dynamics
9.12.1 Fujifilm Cellular Dynamics Immuno-Cell Therapy Basic Information
9.12.2 Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Overview
9.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Market Performance
9.12.4 Fujifilm Cellular Dynamics Business Overview
9.12.5 Fujifilm Cellular Dynamics Recent Developments
9.13 JCR Pharmaceuticals
9.13.1 JCR Pharmaceuticals Immuno-Cell Therapy Basic Information
9.13.2 JCR Pharmaceuticals Immuno-Cell Therapy Product Overview
9.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Product Market Performance
9.13.4 JCR Pharmaceuticals Business Overview
9.13.5 JCR Pharmaceuticals Recent Developments
9.14 Beike Biotechnology
9.14.1 Beike Biotechnology Immuno-Cell Therapy Basic Information
9.14.2 Beike Biotechnology Immuno-Cell Therapy Product Overview
9.14.3 Beike Biotechnology Immuno-Cell Therapy Product Market Performance
9.14.4 Beike Biotechnology Business Overview
9.14.5 Beike Biotechnology Recent Developments
9.15 Golden Meditech
9.15.1 Golden Meditech Immuno-Cell Therapy Basic Information
9.15.2 Golden Meditech Immuno-Cell Therapy Product Overview
9.15.3 Golden Meditech Immuno-Cell Therapy Product Market Performance
9.15.4 Golden Meditech Business Overview
9.15.5 Golden Meditech Recent Developments
9.16 Guanhao Biotech
9.16.1 Guanhao Biotech Immuno-Cell Therapy Basic Information
9.16.2 Guanhao Biotech Immuno-Cell Therapy Product Overview
9.16.3 Guanhao Biotech Immuno-Cell Therapy Product Market Performance
9.16.4 Guanhao Biotech Business Overview
9.16.5 Guanhao Biotech Recent Developments
9.17 Beroni Group
9.17.1 Beroni Group Immuno-Cell Therapy Basic Information
9.17.2 Beroni Group Immuno-Cell Therapy Product Overview
9.17.3 Beroni Group Immuno-Cell Therapy Product Market Performance
9.17.4 Beroni Group Business Overview
9.17.5 Beroni Group Recent Developments
10 IMMUNO-CELL THERAPY MARKET FORECAST BY REGION
10.1 Global Immuno-Cell Therapy Market Size Forecast
10.2 Global Immuno-Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno-Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Immuno-Cell Therapy Market Size Forecast by Region
10.2.4 South America Immuno-Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno-Cell Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Immuno-Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immuno-Cell Therapy by Type (2025-2030)
11.1.2 Global Immuno-Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immuno-Cell Therapy by Type (2025-2030)
11.2 Global Immuno-Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Immuno-Cell Therapy Sales (K Units) Forecast by Application
11.2.2 Global Immuno-Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Immuno-Cell Therapy
1.2 Key Market Segments
1.2.1 Immuno-Cell Therapy Segment by Type
1.2.2 Immuno-Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 IMMUNO-CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Immuno-Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Immuno-Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 IMMUNO-CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Immuno-Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global Immuno-Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Immuno-Cell Therapy Sales Sites, Area Served, Product Type
3.6 Immuno-Cell Therapy Market Competitive Situation and Trends
3.6.1 Immuno-Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 IMMUNO-CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Immuno-Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF IMMUNO-CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 IMMUNO-CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global Immuno-Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Immuno-Cell Therapy Price by Type (2019-2024)
7 IMMUNO-CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-Cell Therapy Market Sales by Application (2019-2024)
7.3 Global Immuno-Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Immuno-Cell Therapy Sales Growth Rate by Application (2019-2024)
8 IMMUNO-CELL THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Immuno-Cell Therapy Sales by Region
8.1.1 Global Immuno-Cell Therapy Sales by Region
8.1.2 Global Immuno-Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 MEDINET Co
9.1.1 MEDINET Co Immuno-Cell Therapy Basic Information
9.1.2 MEDINET Co Immuno-Cell Therapy Product Overview
9.1.3 MEDINET Co Immuno-Cell Therapy Product Market Performance
9.1.4 MEDINET Co Business Overview
9.1.5 MEDINET Co Immuno-Cell Therapy SWOT Analysis
9.1.6 MEDINET Co Recent Developments
9.2 Erytech
9.2.1 Erytech Immuno-Cell Therapy Basic Information
9.2.2 Erytech Immuno-Cell Therapy Product Overview
9.2.3 Erytech Immuno-Cell Therapy Product Market Performance
9.2.4 Erytech Business Overview
9.2.5 Erytech Immuno-Cell Therapy SWOT Analysis
9.2.6 Erytech Recent Developments
9.3 Seta Clinic Group
9.3.1 Seta Clinic Group Immuno-Cell Therapy Basic Information
9.3.2 Seta Clinic Group Immuno-Cell Therapy Product Overview
9.3.3 Seta Clinic Group Immuno-Cell Therapy Product Market Performance
9.3.4 Seta Clinic Group Immuno-Cell Therapy SWOT Analysis
9.3.5 Seta Clinic Group Business Overview
9.3.6 Seta Clinic Group Recent Developments
9.4 Takeda
9.4.1 Takeda Immuno-Cell Therapy Basic Information
9.4.2 Takeda Immuno-Cell Therapy Product Overview
9.4.3 Takeda Immuno-Cell Therapy Product Market Performance
9.4.4 Takeda Business Overview
9.4.5 Takeda Recent Developments
9.5 SBI Holdings
9.5.1 SBI Holdings Immuno-Cell Therapy Basic Information
9.5.2 SBI Holdings Immuno-Cell Therapy Product Overview
9.5.3 SBI Holdings Immuno-Cell Therapy Product Market Performance
9.5.4 SBI Holdings Business Overview
9.5.5 SBI Holdings Recent Developments
9.6 Oxford BioTherapeutics
9.6.1 Oxford BioTherapeutics Immuno-Cell Therapy Basic Information
9.6.2 Oxford BioTherapeutics Immuno-Cell Therapy Product Overview
9.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Product Market Performance
9.6.4 Oxford BioTherapeutics Business Overview
9.6.5 Oxford BioTherapeutics Recent Developments
9.7 Fate Therapeutics
9.7.1 Fate Therapeutics Immuno-Cell Therapy Basic Information
9.7.2 Fate Therapeutics Immuno-Cell Therapy Product Overview
9.7.3 Fate Therapeutics Immuno-Cell Therapy Product Market Performance
9.7.4 Fate Therapeutics Business Overview
9.7.5 Fate Therapeutics Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Immuno-Cell Therapy Basic Information
9.8.2 Gilead Sciences Immuno-Cell Therapy Product Overview
9.8.3 Gilead Sciences Immuno-Cell Therapy Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 Novartis
9.9.1 Novartis Immuno-Cell Therapy Basic Information
9.9.2 Novartis Immuno-Cell Therapy Product Overview
9.9.3 Novartis Immuno-Cell Therapy Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Osiris
9.10.1 Osiris Immuno-Cell Therapy Basic Information
9.10.2 Osiris Immuno-Cell Therapy Product Overview
9.10.3 Osiris Immuno-Cell Therapy Product Market Performance
9.10.4 Osiris Business Overview
9.10.5 Osiris Recent Developments
9.11 Vericel Corporation
9.11.1 Vericel Corporation Immuno-Cell Therapy Basic Information
9.11.2 Vericel Corporation Immuno-Cell Therapy Product Overview
9.11.3 Vericel Corporation Immuno-Cell Therapy Product Market Performance
9.11.4 Vericel Corporation Business Overview
9.11.5 Vericel Corporation Recent Developments
9.12 Fujifilm Cellular Dynamics
9.12.1 Fujifilm Cellular Dynamics Immuno-Cell Therapy Basic Information
9.12.2 Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Overview
9.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Market Performance
9.12.4 Fujifilm Cellular Dynamics Business Overview
9.12.5 Fujifilm Cellular Dynamics Recent Developments
9.13 JCR Pharmaceuticals
9.13.1 JCR Pharmaceuticals Immuno-Cell Therapy Basic Information
9.13.2 JCR Pharmaceuticals Immuno-Cell Therapy Product Overview
9.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Product Market Performance
9.13.4 JCR Pharmaceuticals Business Overview
9.13.5 JCR Pharmaceuticals Recent Developments
9.14 Beike Biotechnology
9.14.1 Beike Biotechnology Immuno-Cell Therapy Basic Information
9.14.2 Beike Biotechnology Immuno-Cell Therapy Product Overview
9.14.3 Beike Biotechnology Immuno-Cell Therapy Product Market Performance
9.14.4 Beike Biotechnology Business Overview
9.14.5 Beike Biotechnology Recent Developments
9.15 Golden Meditech
9.15.1 Golden Meditech Immuno-Cell Therapy Basic Information
9.15.2 Golden Meditech Immuno-Cell Therapy Product Overview
9.15.3 Golden Meditech Immuno-Cell Therapy Product Market Performance
9.15.4 Golden Meditech Business Overview
9.15.5 Golden Meditech Recent Developments
9.16 Guanhao Biotech
9.16.1 Guanhao Biotech Immuno-Cell Therapy Basic Information
9.16.2 Guanhao Biotech Immuno-Cell Therapy Product Overview
9.16.3 Guanhao Biotech Immuno-Cell Therapy Product Market Performance
9.16.4 Guanhao Biotech Business Overview
9.16.5 Guanhao Biotech Recent Developments
9.17 Beroni Group
9.17.1 Beroni Group Immuno-Cell Therapy Basic Information
9.17.2 Beroni Group Immuno-Cell Therapy Product Overview
9.17.3 Beroni Group Immuno-Cell Therapy Product Market Performance
9.17.4 Beroni Group Business Overview
9.17.5 Beroni Group Recent Developments
10 IMMUNO-CELL THERAPY MARKET FORECAST BY REGION
10.1 Global Immuno-Cell Therapy Market Size Forecast
10.2 Global Immuno-Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno-Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Immuno-Cell Therapy Market Size Forecast by Region
10.2.4 South America Immuno-Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno-Cell Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Immuno-Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Immuno-Cell Therapy by Type (2025-2030)
11.1.2 Global Immuno-Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Immuno-Cell Therapy by Type (2025-2030)
11.2 Global Immuno-Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Immuno-Cell Therapy Sales (K Units) Forecast by Application
11.2.2 Global Immuno-Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno-Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Immuno-Cell Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Immuno-Cell Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immuno-Cell Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immuno-Cell Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2022)
Table 10. Global Market Immuno-Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immuno-Cell Therapy Sales Sites and Area Served
Table 12. Manufacturers Immuno-Cell Therapy Product Type
Table 13. Global Immuno-Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immuno-Cell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-Cell Therapy Market Challenges
Table 22. Global Immuno-Cell Therapy Sales by Type (K Units)
Table 23. Global Immuno-Cell Therapy Market Size by Type (M USD)
Table 24. Global Immuno-Cell Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Immuno-Cell Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Immuno-Cell Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Immuno-Cell Therapy Market Size Share by Type (2019-2024)
Table 28. Global Immuno-Cell Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Immuno-Cell Therapy Sales (K Units) by Application
Table 30. Global Immuno-Cell Therapy Market Size by Application
Table 31. Global Immuno-Cell Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Immuno-Cell Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Immuno-Cell Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Immuno-Cell Therapy Market Share by Application (2019-2024)
Table 35. Global Immuno-Cell Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Immuno-Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Immuno-Cell Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Immuno-Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Immuno-Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Immuno-Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Immuno-Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Immuno-Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 43. MEDINET Co Immuno-Cell Therapy Basic Information
Table 44. MEDINET Co Immuno-Cell Therapy Product Overview
Table 45. MEDINET Co Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. MEDINET Co Business Overview
Table 47. MEDINET Co Immuno-Cell Therapy SWOT Analysis
Table 48. MEDINET Co Recent Developments
Table 49. Erytech Immuno-Cell Therapy Basic Information
Table 50. Erytech Immuno-Cell Therapy Product Overview
Table 51. Erytech Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Erytech Business Overview
Table 53. Erytech Immuno-Cell Therapy SWOT Analysis
Table 54. Erytech Recent Developments
Table 55. Seta Clinic Group Immuno-Cell Therapy Basic Information
Table 56. Seta Clinic Group Immuno-Cell Therapy Product Overview
Table 57. Seta Clinic Group Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Seta Clinic Group Immuno-Cell Therapy SWOT Analysis
Table 59. Seta Clinic Group Business Overview
Table 60. Seta Clinic Group Recent Developments
Table 61. Takeda Immuno-Cell Therapy Basic Information
Table 62. Takeda Immuno-Cell Therapy Product Overview
Table 63. Takeda Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Business Overview
Table 65. Takeda Recent Developments
Table 66. SBI Holdings Immuno-Cell Therapy Basic Information
Table 67. SBI Holdings Immuno-Cell Therapy Product Overview
Table 68. SBI Holdings Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. SBI Holdings Business Overview
Table 70. SBI Holdings Recent Developments
Table 71. Oxford BioTherapeutics Immuno-Cell Therapy Basic Information
Table 72. Oxford BioTherapeutics Immuno-Cell Therapy Product Overview
Table 73. Oxford BioTherapeutics Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Oxford BioTherapeutics Business Overview
Table 75. Oxford BioTherapeutics Recent Developments
Table 76. Fate Therapeutics Immuno-Cell Therapy Basic Information
Table 77. Fate Therapeutics Immuno-Cell Therapy Product Overview
Table 78. Fate Therapeutics Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Fate Therapeutics Business Overview
Table 80. Fate Therapeutics Recent Developments
Table 81. Gilead Sciences Immuno-Cell Therapy Basic Information
Table 82. Gilead Sciences Immuno-Cell Therapy Product Overview
Table 83. Gilead Sciences Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. Novartis Immuno-Cell Therapy Basic Information
Table 87. Novartis Immuno-Cell Therapy Product Overview
Table 88. Novartis Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Novartis Business Overview
Table 90. Novartis Recent Developments
Table 91. Osiris Immuno-Cell Therapy Basic Information
Table 92. Osiris Immuno-Cell Therapy Product Overview
Table 93. Osiris Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Osiris Business Overview
Table 95. Osiris Recent Developments
Table 96. Vericel Corporation Immuno-Cell Therapy Basic Information
Table 97. Vericel Corporation Immuno-Cell Therapy Product Overview
Table 98. Vericel Corporation Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Vericel Corporation Business Overview
Table 100. Vericel Corporation Recent Developments
Table 101. Fujifilm Cellular Dynamics Immuno-Cell Therapy Basic Information
Table 102. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Overview
Table 103. Fujifilm Cellular Dynamics Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Fujifilm Cellular Dynamics Business Overview
Table 105. Fujifilm Cellular Dynamics Recent Developments
Table 106. JCR Pharmaceuticals Immuno-Cell Therapy Basic Information
Table 107. JCR Pharmaceuticals Immuno-Cell Therapy Product Overview
Table 108. JCR Pharmaceuticals Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. JCR Pharmaceuticals Business Overview
Table 110. JCR Pharmaceuticals Recent Developments
Table 111. Beike Biotechnology Immuno-Cell Therapy Basic Information
Table 112. Beike Biotechnology Immuno-Cell Therapy Product Overview
Table 113. Beike Biotechnology Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Beike Biotechnology Business Overview
Table 115. Beike Biotechnology Recent Developments
Table 116. Golden Meditech Immuno-Cell Therapy Basic Information
Table 117. Golden Meditech Immuno-Cell Therapy Product Overview
Table 118. Golden Meditech Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Golden Meditech Business Overview
Table 120. Golden Meditech Recent Developments
Table 121. Guanhao Biotech Immuno-Cell Therapy Basic Information
Table 122. Guanhao Biotech Immuno-Cell Therapy Product Overview
Table 123. Guanhao Biotech Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Guanhao Biotech Business Overview
Table 125. Guanhao Biotech Recent Developments
Table 126. Beroni Group Immuno-Cell Therapy Basic Information
Table 127. Beroni Group Immuno-Cell Therapy Product Overview
Table 128. Beroni Group Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Beroni Group Business Overview
Table 130. Beroni Group Recent Developments
Table 131. Global Immuno-Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Immuno-Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Immuno-Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Immuno-Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Immuno-Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Immuno-Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Immuno-Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Immuno-Cell Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Immuno-Cell Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Immuno-Cell Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Immuno-Cell Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Immuno-Cell Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Immuno-Cell Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno-Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Immuno-Cell Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Immuno-Cell Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Immuno-Cell Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Immuno-Cell Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2022)
Table 10. Global Market Immuno-Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Immuno-Cell Therapy Sales Sites and Area Served
Table 12. Manufacturers Immuno-Cell Therapy Product Type
Table 13. Global Immuno-Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immuno-Cell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-Cell Therapy Market Challenges
Table 22. Global Immuno-Cell Therapy Sales by Type (K Units)
Table 23. Global Immuno-Cell Therapy Market Size by Type (M USD)
Table 24. Global Immuno-Cell Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Immuno-Cell Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Immuno-Cell Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Immuno-Cell Therapy Market Size Share by Type (2019-2024)
Table 28. Global Immuno-Cell Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Immuno-Cell Therapy Sales (K Units) by Application
Table 30. Global Immuno-Cell Therapy Market Size by Application
Table 31. Global Immuno-Cell Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Immuno-Cell Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Immuno-Cell Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Immuno-Cell Therapy Market Share by Application (2019-2024)
Table 35. Global Immuno-Cell Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Immuno-Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Immuno-Cell Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Immuno-Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Immuno-Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Immuno-Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Immuno-Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Immuno-Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 43. MEDINET Co Immuno-Cell Therapy Basic Information
Table 44. MEDINET Co Immuno-Cell Therapy Product Overview
Table 45. MEDINET Co Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. MEDINET Co Business Overview
Table 47. MEDINET Co Immuno-Cell Therapy SWOT Analysis
Table 48. MEDINET Co Recent Developments
Table 49. Erytech Immuno-Cell Therapy Basic Information
Table 50. Erytech Immuno-Cell Therapy Product Overview
Table 51. Erytech Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Erytech Business Overview
Table 53. Erytech Immuno-Cell Therapy SWOT Analysis
Table 54. Erytech Recent Developments
Table 55. Seta Clinic Group Immuno-Cell Therapy Basic Information
Table 56. Seta Clinic Group Immuno-Cell Therapy Product Overview
Table 57. Seta Clinic Group Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Seta Clinic Group Immuno-Cell Therapy SWOT Analysis
Table 59. Seta Clinic Group Business Overview
Table 60. Seta Clinic Group Recent Developments
Table 61. Takeda Immuno-Cell Therapy Basic Information
Table 62. Takeda Immuno-Cell Therapy Product Overview
Table 63. Takeda Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Business Overview
Table 65. Takeda Recent Developments
Table 66. SBI Holdings Immuno-Cell Therapy Basic Information
Table 67. SBI Holdings Immuno-Cell Therapy Product Overview
Table 68. SBI Holdings Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. SBI Holdings Business Overview
Table 70. SBI Holdings Recent Developments
Table 71. Oxford BioTherapeutics Immuno-Cell Therapy Basic Information
Table 72. Oxford BioTherapeutics Immuno-Cell Therapy Product Overview
Table 73. Oxford BioTherapeutics Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Oxford BioTherapeutics Business Overview
Table 75. Oxford BioTherapeutics Recent Developments
Table 76. Fate Therapeutics Immuno-Cell Therapy Basic Information
Table 77. Fate Therapeutics Immuno-Cell Therapy Product Overview
Table 78. Fate Therapeutics Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Fate Therapeutics Business Overview
Table 80. Fate Therapeutics Recent Developments
Table 81. Gilead Sciences Immuno-Cell Therapy Basic Information
Table 82. Gilead Sciences Immuno-Cell Therapy Product Overview
Table 83. Gilead Sciences Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. Novartis Immuno-Cell Therapy Basic Information
Table 87. Novartis Immuno-Cell Therapy Product Overview
Table 88. Novartis Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Novartis Business Overview
Table 90. Novartis Recent Developments
Table 91. Osiris Immuno-Cell Therapy Basic Information
Table 92. Osiris Immuno-Cell Therapy Product Overview
Table 93. Osiris Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Osiris Business Overview
Table 95. Osiris Recent Developments
Table 96. Vericel Corporation Immuno-Cell Therapy Basic Information
Table 97. Vericel Corporation Immuno-Cell Therapy Product Overview
Table 98. Vericel Corporation Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Vericel Corporation Business Overview
Table 100. Vericel Corporation Recent Developments
Table 101. Fujifilm Cellular Dynamics Immuno-Cell Therapy Basic Information
Table 102. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Overview
Table 103. Fujifilm Cellular Dynamics Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Fujifilm Cellular Dynamics Business Overview
Table 105. Fujifilm Cellular Dynamics Recent Developments
Table 106. JCR Pharmaceuticals Immuno-Cell Therapy Basic Information
Table 107. JCR Pharmaceuticals Immuno-Cell Therapy Product Overview
Table 108. JCR Pharmaceuticals Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. JCR Pharmaceuticals Business Overview
Table 110. JCR Pharmaceuticals Recent Developments
Table 111. Beike Biotechnology Immuno-Cell Therapy Basic Information
Table 112. Beike Biotechnology Immuno-Cell Therapy Product Overview
Table 113. Beike Biotechnology Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Beike Biotechnology Business Overview
Table 115. Beike Biotechnology Recent Developments
Table 116. Golden Meditech Immuno-Cell Therapy Basic Information
Table 117. Golden Meditech Immuno-Cell Therapy Product Overview
Table 118. Golden Meditech Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Golden Meditech Business Overview
Table 120. Golden Meditech Recent Developments
Table 121. Guanhao Biotech Immuno-Cell Therapy Basic Information
Table 122. Guanhao Biotech Immuno-Cell Therapy Product Overview
Table 123. Guanhao Biotech Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Guanhao Biotech Business Overview
Table 125. Guanhao Biotech Recent Developments
Table 126. Beroni Group Immuno-Cell Therapy Basic Information
Table 127. Beroni Group Immuno-Cell Therapy Product Overview
Table 128. Beroni Group Immuno-Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Beroni Group Business Overview
Table 130. Beroni Group Recent Developments
Table 131. Global Immuno-Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global Immuno-Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Immuno-Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Immuno-Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Immuno-Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific Immuno-Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Immuno-Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Immuno-Cell Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Immuno-Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Immuno-Cell Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global Immuno-Cell Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Immuno-Cell Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global Immuno-Cell Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global Immuno-Cell Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Immuno-Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-Cell Therapy Market Size (M USD), 2019-2030
Figure 5. Global Immuno-Cell Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Immuno-Cell Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-Cell Therapy Market Size by Country (M USD)
Figure 11. Immuno-Cell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Immuno-Cell Therapy Revenue Share by Manufacturers in 2023
Figure 13. Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immuno-Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immuno-Cell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immuno-Cell Therapy Market Share by Type
Figure 18. Sales Market Share of Immuno-Cell Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Immuno-Cell Therapy by Type in 2023
Figure 20. Market Size Share of Immuno-Cell Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Immuno-Cell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immuno-Cell Therapy Market Share by Application
Figure 24. Global Immuno-Cell Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Immuno-Cell Therapy Sales Market Share by Application in 2023
Figure 26. Global Immuno-Cell Therapy Market Share by Application (2019-2024)
Figure 27. Global Immuno-Cell Therapy Market Share by Application in 2023
Figure 28. Global Immuno-Cell Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immuno-Cell Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Immuno-Cell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Immuno-Cell Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Immuno-Cell Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Immuno-Cell Therapy Sales Market Share by Country in 2023
Figure 37. Germany Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Immuno-Cell Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Immuno-Cell Therapy Sales Market Share by Region in 2023
Figure 44. China Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Immuno-Cell Therapy Sales and Growth Rate (K Units)
Figure 50. South America Immuno-Cell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Immuno-Cell Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Immuno-Cell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Immuno-Cell Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Immuno-Cell Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immuno-Cell Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immuno-Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Immuno-Cell Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Immuno-Cell Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Immuno-Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-Cell Therapy Market Size (M USD), 2019-2030
Figure 5. Global Immuno-Cell Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Immuno-Cell Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-Cell Therapy Market Size by Country (M USD)
Figure 11. Immuno-Cell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Immuno-Cell Therapy Revenue Share by Manufacturers in 2023
Figure 13. Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immuno-Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immuno-Cell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immuno-Cell Therapy Market Share by Type
Figure 18. Sales Market Share of Immuno-Cell Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Immuno-Cell Therapy by Type in 2023
Figure 20. Market Size Share of Immuno-Cell Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Immuno-Cell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immuno-Cell Therapy Market Share by Application
Figure 24. Global Immuno-Cell Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Immuno-Cell Therapy Sales Market Share by Application in 2023
Figure 26. Global Immuno-Cell Therapy Market Share by Application (2019-2024)
Figure 27. Global Immuno-Cell Therapy Market Share by Application in 2023
Figure 28. Global Immuno-Cell Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Immuno-Cell Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Immuno-Cell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Immuno-Cell Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Immuno-Cell Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Immuno-Cell Therapy Sales Market Share by Country in 2023
Figure 37. Germany Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Immuno-Cell Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Immuno-Cell Therapy Sales Market Share by Region in 2023
Figure 44. China Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Immuno-Cell Therapy Sales and Growth Rate (K Units)
Figure 50. South America Immuno-Cell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Immuno-Cell Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Immuno-Cell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Immuno-Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Immuno-Cell Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Immuno-Cell Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Immuno-Cell Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Immuno-Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Immuno-Cell Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Immuno-Cell Therapy Market Share Forecast by Application (2025-2030)
